Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-08-26 ORBIMED ADVISORS LLC Director Sale −83,695 $13.00 $1.1M 0
2024-08-23 ORBIMED ADVISORS LLC Director Sale −69,500 $13.03 $906K 83,695
2024-08-22 ORBIMED ADVISORS LLC Director Sale −391,482 $12.94 $5.1M 153,195
2024-08-21 ORBIMED ADVISORS LLC Director Sale −394,400 $13.52 $5.3M 557,977
2024-08-21 ORBIMED ADVISORS LLC Director Sale −13,300 $14.61 $194K 544,677
2023-08-29 ORBIMED ADVISORS LLC Director Purchase +500,000 $6.20 $3.1M 8,019,187
2020-12-08 ORBIMED ADVISORS LLC Director Purchase +238,100 $21.00 $5.0M 507,423
2020-12-08 ORBIMED ADVISORS LLC Director Conversion +3,462,737 3,970,160
2020-12-08 ORBIMED ADVISORS LLC Director Conversion +2,493,741 6,463,901
2020-12-08 ORBIMED ADVISORS LLC Director Conversion +1,055,287 7,519,188
2020-12-08 ORBIMED ADVISORS LLC Director Purchase +952,377 $21.00 $20.0M 952,377
2020-12-08 ORBIMED ADVISORS LLC Director Conversion · Series A Preferred Stock −12,857,142 0
2020-12-08 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −9,259,259 0
2020-12-08 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −3,918,279 0

Page 1 of 1 · 14 trades